Week In Review: $1.5 Billion Total In Week's China Deals
October 10, 2020 at 14:04 PM EDT
Everest Medicines of Shanghai completed a $451 million IPO in Hong Kong to develop its portfolio of eight assets in-licensed for China development. The company's stock climbed 32% in its first trading session.